{"id":2104,"date":"2026-06-26T11:37:38","date_gmt":"2026-06-26T02:37:38","guid":{"rendered":"https:\/\/lmi.jp\/articles\/?p=2104"},"modified":"2026-06-26T14:00:05","modified_gmt":"2026-06-26T05:00:05","slug":"unraveling-the-genomic-imprint-of-hbv-in-hepatocarcinogenesis","status":"publish","type":"post","link":"https:\/\/lmi.jp\/articles\/2026\/06\/26\/unraveling-the-genomic-imprint-of-hbv-in-hepatocarcinogenesis\/","title":{"rendered":"Unraveling the Genomic Imprint of HBV in Hepatocarcinogenesis"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><br><a href=\"https:\/\/lmi.jp\/articles\/?s=Hiroyasu+Ito\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Hiroyasu Ito<\/strong><\/a>*<\/p>\n\n\n\n<div class=\"swell-block-accordion\">\n<details class=\"swell-block-accordion__item\" data-swl-acc=\"wrapper\"><summary class=\"swell-block-accordion__title\" data-swl-acc=\"header\"><span class=\"swell-block-accordion__label\"><span style=\"--the-icon-svg: url(data:image\/svg+xml;base64,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)\" data-icon=\"Ph1pencilSimple\" data-id=\"0\" aria-hidden=\"true\" class=\"swl-inline-icon\">\u2003 Cite<\/span><\/span><span class=\"swell-block-accordion__icon c-switchIconBtn\" data-swl-acc=\"icon\" aria-hidden=\"true\" data-opened=\"false\"><i class=\"__icon--closed icon-caret-down\"><\/i><i class=\"__icon--opened icon-caret-up\"><\/i><\/span><\/summary><div class=\"swell-block-accordion__body\" data-swl-acc=\"body\">\n<p class=\"wp-block-paragraph\">Ito H. Unraveling the Genomic Imprint of HBV in Hepatocarcinogenesis. Lab Med Int 2026; 5(1): 1-2: doi.org\/10.51041\/lmi.5.1_1<\/p>\n<\/div><\/details>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Editorial<br>Lab Med Int 2026; 5(1): 1-2<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">*Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University, 1-98 Dengakugakubo,<br>Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.<br>E-mail: hiroyasu.ito&#8221;@&#8221;fujita-hu.ac.jp<\/p>\n\n\n\n<div class=\"swell-block-button is-style-more_btn\"><a href=\"https:\/\/lmi.jp\/articles\/wp\/wp-content\/uploads\/2026\/04\/01_Editorial_Dr-Ito.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"swell-block-button__link\"><span>Download PDF<\/span><\/a><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>See article volume 5<\/strong>(<strong>1<\/strong>)<strong>: 3-19<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In this comprehensive review, Dr. Ogata presents a masterful synthesis of four decades of investigation into hepatitis B virus (HBV) integration and its role in hepatocellular carcinoma (HCC) development, a relationship first highlighted in early molecular studies. Advances in sequencing technologies\u2014from Southern blotting and Sanger sequencing to second- and third-generation sequencing\u2014have progressively refined our understanding of how HBV integrates into the human genome, particularly within repetitive genomic regions<sup><strong>1)<\/strong><\/sup>. One of the most striking contributions detailed in this review is the discovery of HBV integration into centromeric alpha satellite DNA (\u03b1Sat), first reported by Dr. Ogata. This finding was later reinforced by computational approaches such as SurVirus<sup><strong>2)<\/strong><\/sup> and long-read sequencing analyses<sup><strong>3)<\/strong><\/sup>, which highlighted the centromere\u2014previously inaccessible due to its repetitive structure\u2014as a key locus where HBV-induced genomic instability may originate. The ability of HBV to integrate into \u03b1Sat suggests a direct mechanism between viral infection, disruption of centromere function, and aneuploidy, widely observed in HCC. This review also places HBV integration within broader cancer genomics efforts including TCGA and ICGC projects, which revealed that HBV frequently targets major cancer-related genes such as <em>TERT<\/em>, <em>KMT2B<\/em>, and <em>CCNE1<\/em><sup><strong>1)4)<\/strong><\/sup>. Structural variations (SVs)\u2014including chromosomal amplifications, deletions, and translocations\u2014were shown to colocalize with HBV integration sites, with some SVs occurring decades before clinical HCC diagnosis<sup>4)<\/sup>. Long-read sequencing has further clarified these events, revealing that HBV can induce not only local but also distant genomic alterations, reshaping the tumor genome in profound ways<sup><strong>3)<\/strong><\/sup>. Beyond genomic mapping, emerging proteogenomic insights show that although HBV-derived proteins may be detectable in HCC tissues, their expression does not strongly correlate with clinical outcomes<sup><strong>5)<\/strong><\/sup>. These results suggest that while HBV protein expression may diminish over time, the genomic scars left behind\u2014such as HBV-driven SVs\u2014continue to influence tumor biology. The clinical implications of these findings are likely to be significant. Advances in liquid biopsy technology\u2014including methylated DNA assays and cfDNA-based repeat profiling\u2014have enabled promising new avenues for early HCC detection<sup><strong>6)<\/strong><\/sup>. Meanwhile, therapeutic strategies targeting telomerase, particularly anti-<em>TERT<\/em> approaches, have gained increasing traction due to the central role of <em>TERT<\/em> activation in HBV-related HCC<sup><strong>7)<\/strong><\/sup>. Taken together, this review illustrates a cohesive narrative: HBV integration is not a random genomic event but a structured, biologically significant process that interacts with centromeric biology, genomic stability, and cancer evolution. As long-read sequencing and telomere-to-telomere genome assemblies mature, repetitive DNA elements\u2014once viewed as \u201cgenetic dark matter\u201d\u2014are emerging as critical components in understanding HBV-mediated hepatocarcinogenesis<sup><strong>8)<\/strong><\/sup>. This review not only synthesizes past knowledge but also illuminates future directions, urging deeper investigation into HBV integration within repetitive genomic elements and its implications for prevention, early detection, and personalized therapy of HBV-related HCC.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>References<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Totoki Y, Tatsuno K, Covington KR, et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet. 2014; 46(12): 1267-73.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25362482\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n\n\n\n<li>Rajaby R, Zhou Y, Meng Y, et al. SurVirus: a repeat-aware virus integration caller. Nucleic Acids Res. 2021; 49(6): e33.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33444454\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n\n\n\n<li>Zhuo Z, Rong W, Li H, et al. Long-read sequencing reveals the structural complexity of genomic integration of HBV DNA in hepatocellular carcinoma. NPJ Genom Med. 2021; 6(1): 84.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34642322\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n\n\n\n<li>Qian Z, Liang J, Huang R, et al. HBV integrations reshaping genomic structures promote hepatocellular carcinoma. Gut. 2024; 73(7): 1169-82.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38395437\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n\n\n\n<li>Gao Q, Zhu H, Doung L, et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell. 2019; 179(2): 561-77.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31585088\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n\n\n\n<li>Sun J, Sun X, He W, et al. A liquid biopsy approach detects HCC and identifies GJA4 as a potential biomarker for HBV-HCC via plasma cfDNA methylome profiling. Clin Epigenetics. 2025; 17(1): 98.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40500793\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n\n\n\n<li>Ningarhari M, Caruso S, Hirsch TZ, et al. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target. J Hepatol. 2021; 74(5): 1155-66.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33338512\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n\n\n\n<li>Altemose N, Logsdon GA, Bzikadze AV, et al. Complete genomic and epigenetic maps of human centromeres. Science. 2022; 376(6588): eabl4178.<span class=\"swl-inline-btn is-style-btn_normal red_\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35357911\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/span><\/li>\n<\/ol>\n\n\n\n<p class=\"has-border -border01 wp-block-paragraph\">This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hiroyasu Ito* EditorialLab Med Int 2026; 5(1): 1-2 *Department of Joint Research Laboratory of Clinical Medici [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2107,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"swell_btn_cv_data":"","footnotes":""},"categories":[180,179],"tags":[183],"class_list":["post-2104","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-editorial-lab-med-int-2026-51","category-lab-med-int-2026-51","tag-lab-med-int-2026-51"],"_links":{"self":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts\/2104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/comments?post=2104"}],"version-history":[{"count":5,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts\/2104\/revisions"}],"predecessor-version":[{"id":2115,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts\/2104\/revisions\/2115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/media\/2107"}],"wp:attachment":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/media?parent=2104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/categories?post=2104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/tags?post=2104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}